rs199680570
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting
The NM_178452.6(DNAAF1):āc.1990A>Cā(p.Thr664Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000446 in 1,613,332 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_178452.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAAF1 | NM_178452.6 | c.1990A>C | p.Thr664Pro | missense_variant | 11/12 | ENST00000378553.10 | NP_848547.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAAF1 | ENST00000378553.10 | c.1990A>C | p.Thr664Pro | missense_variant | 11/12 | 1 | NM_178452.6 | ENSP00000367815.5 |
Frequencies
GnomAD3 genomes AF: 0.000270 AC: 41AN: 152078Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000799 AC: 20AN: 250294Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135616
GnomAD4 exome AF: 0.0000212 AC: 31AN: 1461254Hom.: 0 Cov.: 51 AF XY: 0.0000110 AC XY: 8AN XY: 726958
GnomAD4 genome AF: 0.000270 AC: 41AN: 152078Hom.: 0 Cov.: 33 AF XY: 0.000296 AC XY: 22AN XY: 74290
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 08, 2022 | This sequence change replaces threonine, which is neutral and polar, with proline, which is neutral and non-polar, at codon 664 of the DNAAF1 protein (p.Thr664Pro). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with DNAAF1-related conditions. ClinVar contains an entry for this variant (Variation ID: 455003). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 09, 2023 | The c.1990A>C (p.T664P) alteration is located in exon 11 (coding exon 11) of the DNAAF1 gene. This alteration results from a A to C substitution at nucleotide position 1990, causing the threonine (T) at amino acid position 664 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jul 05, 2018 | Variant classified as Uncertain Significance - Favor Benign. The p.Thr664Pro var iant in DNAAF1 has not been previously reported in individuals with pulmonary di sease but has been identified in 0.1% (12/8722) of African chromosomes by the Ge nome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs199 680570). This variant has also been reported in ClinVar (Variation ID 455003). C omputational prediction tools and conservation analysis suggest that the p.Thr66 4Pro variant may not impact the protein, though this information is not predicti ve enough to rule out pathogenicity. In summary, while the clinical significance of the p.Thr664Pro variant is uncertain, its frequency suggests that it is more likely to be benign. ACMG/AMP Criteria applied: BP4. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at